
Phu Hoang Nguyen
Examiner (ID: 14741, Phone: (571)272-5931 , Office: P/1747 )
| Most Active Art Unit | 1747 |
| Art Unit(s) | 1731, 1747, 1791 |
| Total Applications | 942 |
| Issued Applications | 511 |
| Pending Applications | 112 |
| Abandoned Applications | 343 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15114209
[patent_doc_number] => 20190343737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => Oral Care Compositions Comprising Fluoride Ions
[patent_app_type] => utility
[patent_app_number] => 16/411181
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411181 | Oral care compositions comprising fluoride ions | May 13, 2019 | Issued |
Array
(
[id] => 15114201
[patent_doc_number] => 20190343733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => Oral Care Compositions Comprising Metal Ions
[patent_app_type] => utility
[patent_app_number] => 16/411180
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411180 | Oral care compositions comprising metal ions | May 13, 2019 | Issued |
Array
(
[id] => 17362608
[patent_doc_number] => 11229616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Pharmaceutical composition for controlled release of treprostinil
[patent_app_type] => utility
[patent_app_number] => 16/404272
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 8883
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404272 | Pharmaceutical composition for controlled release of treprostinil | May 5, 2019 | Issued |
Array
(
[id] => 16882920
[patent_doc_number] => 20210169115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => NEONATAL PARENTERAL NUTRITION FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/052361
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052361 | NEONATAL PARENTERAL NUTRITION FORMULATIONS | Apr 30, 2019 | Abandoned |
Array
(
[id] => 18716422
[patent_doc_number] => 11793743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Compositions comprising acetone, a monoalcohol, glycerin, and cellulose thickener
[patent_app_type] => utility
[patent_app_number] => 16/397492
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4415
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397492 | Compositions comprising acetone, a monoalcohol, glycerin, and cellulose thickener | Apr 28, 2019 | Issued |
Array
(
[id] => 14774903
[patent_doc_number] => 20190262349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/388620
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16388620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/388620 | Corticotropin releasing factor receptor antagonists | Apr 17, 2019 | Issued |
Array
(
[id] => 15020569
[patent_doc_number] => 20190321289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/386920
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16386920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/386920 | DRUG DELIVERY SYSTEM | Apr 16, 2019 | Abandoned |
Array
(
[id] => 14963075
[patent_doc_number] => 20190309015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => LIPOSOMAL METHODS FOR PURIFICATION OF PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/377989
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377989 | LIPOSOMAL METHODS FOR PURIFICATION OF PROTEINS | Apr 7, 2019 | Abandoned |
Array
(
[id] => 14990595
[patent_doc_number] => 20190314255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Cleansing Concentrate Composition
[patent_app_type] => utility
[patent_app_number] => 16/371662
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371662 | Cleansing Concentrate Composition | Mar 31, 2019 | Abandoned |
Array
(
[id] => 16805922
[patent_doc_number] => 20210128475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SUSTAINED-RELEASE ANESTHETIC COMPOSITIONS AND METHODS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/043920
[patent_app_country] => US
[patent_app_date] => 2019-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043920 | Sustained-release anesthetic compositions and methods of preparation thereof | Mar 29, 2019 | Issued |
Array
(
[id] => 16898811
[patent_doc_number] => 20210177727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => EXTRACTS OF PLANTS CONTAINING POLYGODIAL, COMPOSITIONS COMPRISING SUCH EXTRACTS AND COSMETIC AND/OR DERMATOLOGICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/046823
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046823 | Extracts of plants containing polygodial, compositions comprising such extracts and cosmetic and/or dermatological uses thereof | Mar 28, 2019 | Issued |
Array
(
[id] => 16868348
[patent_doc_number] => 20210161815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Dosing Regimens for Treatment of Proliferative Disorders
[patent_app_type] => utility
[patent_app_number] => 17/045431
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045431 | Dosing regimens for treatment of proliferative disorders | Mar 27, 2019 | Issued |
Array
(
[id] => 16341542
[patent_doc_number] => 20200306192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => IMMEDIATE RELEASE DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/364244
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16364244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/364244 | Immediate release dosage form | Mar 25, 2019 | Issued |
Array
(
[id] => 15927609
[patent_doc_number] => 20200155438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF PATHOLOGIES OF THE ORAL CAVITY
[patent_app_type] => utility
[patent_app_number] => 16/359122
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359122 | PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF PATHOLOGIES OF THE ORAL CAVITY | Mar 19, 2019 | Abandoned |
Array
(
[id] => 16671442
[patent_doc_number] => 20210060205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/977724
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977724 | AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF | Feb 28, 2019 | Pending |
Array
(
[id] => 14805993
[patent_doc_number] => 20190269606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => TOOTHPASTE COMPOSITION AND METHOD OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 16/284652
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284652
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284652 | Toothpaste composition and method of making same | Feb 24, 2019 | Issued |
Array
(
[id] => 15243417
[patent_doc_number] => 10507218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Treatment of cardiovascular disease by using gallium compounds to bind calcified lesions
[patent_app_type] => utility
[patent_app_number] => 16/281518
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3822
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281518
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281518 | Treatment of cardiovascular disease by using gallium compounds to bind calcified lesions | Feb 20, 2019 | Issued |
Array
(
[id] => 14497689
[patent_doc_number] => 20190192499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => ATROPINE PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/280552
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280552 | Atropine pharmaceutical compositions | Feb 19, 2019 | Issued |
Array
(
[id] => 17088706
[patent_doc_number] => 11116876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Methods and devices for repair of severed peripheral nerves with erythropoietin
[patent_app_type] => utility
[patent_app_number] => 16/280424
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6590
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/280424 | Methods and devices for repair of severed peripheral nerves with erythropoietin | Feb 19, 2019 | Issued |
Array
(
[id] => 17103144
[patent_doc_number] => 11123333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Inhibitors of intracellular invasion
[patent_app_type] => utility
[patent_app_number] => 16/278126
[patent_app_country] => US
[patent_app_date] => 2019-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 12386
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16278126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/278126 | Inhibitors of intracellular invasion | Feb 16, 2019 | Issued |